Overexpression of Retinoic Acid Receptor α in Hepatocellular Carcinoma

Clinical Cancer Research

Volumn 9, Issue 10, 2003, Pages 3679-3683

  Sano, Keiji ^a   Takayama, Tadatoshi ^a   Murakami, Koji ^b   Saiki, Ikuo ^b   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR ALPHA; RETINOID;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASMS; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0141456447     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. El-Serag, H. B., and Mason, A. C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med., 340: 745-750, 1999.
2. Taylor-Robinson, S. D., Foster, G. R., Arora, S., Hargreaves, S., and Thomas, H. C. Increase in primary liver cancer in the UK, 1979-94. Lancet, 350: 1142-1143, 1997.
3. Takayama, T., Makuuchi, M., Hirohashi, S., Sakamoto, M., Yamamoto, J., Shimada, K., Kosuge, T., Okada, S., Takayasu, K., and Yamasaki, S. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology, 28: 1241-1246, 1998.
4. Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K. T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., Nakamura, T., and Kojima, T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N. Engl. J. Med., 340: 1046-1047, 1999.
5. Takayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., and Kakizoe, T. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet, 356: 802-807, 2000.
6. Villa, E., Moles, A., Ferretti, I., Buttafoco, P., Grottola, A., Del Buono, M., De Santis, M., and Manenti, F. Natural history of inoperable hepatocellular carcinoma: estrogen receptor's status in the tumor is the strongest prognostic factor for survival. Hepatology, 32: 233-238, 2000.
7. Venook, A. P. Treatment of hepatocellular carcinoma: too many options? J. Clin. Oncol., 12: 1323-1334, 1994.
8. De Luca, L. M. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J., 5: 2924-2933, 1991.
9. Wang, Z. Y., Sun, G. L., Lu, J. X., Gu, L. J., Huang, M. E., and Chen, S. R. Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China. Nouv. Rev. Fr. Hematol., 32: 34-36, 1990.
10. Muindi, J., Frankel, S. R., Miller, W. H., Jr., Jakubowski, A., Scheinberg, D. A., Young, C. W., Dmitrovsky, E., and Warrell, R. P., Jr. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukemia. Blood, 79: 299-303, 1992.
11. Adedoyin, A., Stiff, D. D., Smith, D. C., Romkes, M., Bahnson, R. C., Day, R., Hofacker, J., Branch, R. A., and Trump, D. L. All-transretinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes. Cancer Chemother. Pharmacol., 41: 133-139, 1998.
12. Meyskens, F. L., Jr., Jakobson, J., Nguyen, B., Weiss, G. R., Gandara, D. R., and MacDonald, J. S. Phase II trial of oral b-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157). Invest. New Drugs, 16: 171-173, 1998.
13. Xu, X. C., Sozzi, G., Lee, J. S., Lee, J. J., Pastorino, U., Pilotti, S., Kurie, J. M., Hong, W. K., and Lotan, R. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development. J. Natl. Cancer Inst. (Bethesda), 7: 624-629, 1997.
14. Sun, S. Y., Yue, P., Dawson, M. I., Shroot, B., Michel, S., Lamph, W. W., Heyman, R. A., Teng, M., Chandraratna, R. A. S., Shudo, K., Hong, W. K., and Lotan, R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res., 57: 4931-4939, 1997.
15. Matsushima-Nishiwaki, R., Shidoji, Y., Nishiwaki, S., Yamada, T., Moriwaki, H., and Muto, Y. Aberrant metabolism of retinoid X receptor proteins in human hepatocellular carcinoma. Mol. Cell. Endocrinol., 121: 179-190, 1996.
16. Adachi, S., Okuno, M., Matsushima-Nishiwaki, R., Takano, Y., Kojima, S., Friedman, S., Moriwaki, H., and Okano, Y. Phosphorylation of retinoic X receptor suppresses its ubiquitination in human hepatocellular carcinoma. Hepatology, 35: 332-340, 2002.
17. Murakami, K., Matsuura, T., Hasumura, S., Nagamori, S., Yamada, Y., and Saiki, I. Involvement of insulin-like growth factor binding protein-3 in the retinoic acid receptor-α-mediated inhibition of hepatocellular carcinoma cell proliferation. Cancer Lett., 151: 63-70, 2000.
18. Murakami, K., Matsuura, T., Sano, M., Hashimoto, A., Yonekura, K., Sakukawa, R., Yamada, Y., and Saiki, I. 4-[3,5-Bis(trimethylsilyl) benzamido]benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumorbearing animals. Clin. Exp. Metastasis, 16: 633-643, 1998.
19. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
20. International Union Against Cancer. Liver. In: L. H. Sobin and C. Wittenkind (eds.), TNM Classification of Malignant Tumours, 5th ed., pp. 74-77. New York: Wiley-Liss, 1997.
21. Sever, C. E., and Locker, J. Expression of retinoic acid and receptor genes in liver and hepatocellular carcinoma. Mol. Carcinog., 4: 138-144, 1991.
22. David, J. M., Umezono, K., and Evans, R. M. The retinoic acid receptors. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, 2nd ed., pp. 319-349. New York: Raven Press, 1994.
23. Hashimoto, Y., Kagechika, H., Kawachi, E., Fukasawa, H., Saito, G., and Shudo, K. Evaluation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. Biol. Pharm. Bull., 19: 1322-1328, 1996.
24. Zhang, L. X., Mills, K. J., Dawson, M. I., Collins, S. J., and Jetten, A. M. Evidence for the involvement of retinoic acid receptor RAR α-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem., 270: 6022-6029, 1995.
25. Pollard, M., and Luckert, P. H. The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats. Cancer Lett., 59: 159163, 1991.
26. Oikawa, T., Okayasu, I., Ashino, H., Morita, I., Murota, S., and Shudo, K. Three novel synthetic retinoids, Re80, Am580, Am80, all exhibit anti-angiogenic activity in vivo. Eur. J. Pharmacol., 249: 113-116, 1993.
27. Lu, X. P., Fanjui, A., Picard, N., Pfahl, M., Rungta, D., Nared-Hood, K., Carter, B., Piedrafita, J., Tang, S., Fabbrizio, E., and Pfahl, M. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med., 3: 686-690, 1997.
28. Murakami, K., Wierzba, K., Sano, M., Shibata, J., Yonekura, K., Hashimoto, A., Sato, K., and Yamada, Y. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span. Clin. Exp. Metastasis, 16: 323-331, 1998.
29. Murakami, K., Yamaura, T., Suda, K., Ohie, S., Shibata, J., Toko, T., Yamada, Y., and Saiki, I. TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Jpn. J. Cancer Res., 90: 1254-1261, 1999.
30. Angel, P., and Karin, M. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
31. Li, J. J., Dong, Z., Dawson, M. I., and Colburn, N. H. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivation retinoic acid response element. Cancer Res., 56: 483-489, 1996.
32. Hui, A. M., and Makuuchi, M. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. Scand. J. Gastroenterol., 34: 737-742, 1999.
33. Yuen, M. F., Wu, P. C., Lai, V. C., Lau, J. Y., and Lai, C. L. Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma. Cancer (Phila.), 91: 106-112, 2001.
34. Takayama, T., Makuuchi, M., Hirohashi, S., Sakamoto, M., Okazaki, N., Takayasu, K., Kosuge, T., Motoo, Y., Yamazaki, S., and Hasegawa, H. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet, 336: 1150-1153, 1990.
35. Sugihara, S., Nakashima, O., Kojiro, M., Majima, Y., Tanaka, M., and Tanikawa, K. The morphologic transition in hepatocellular carcinoma: a comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy. Cancer (Phila.), 70: 1488-1492, 1992.
36. Sun, S. Y., Kurie, J. M., Yue, P., Dawson, M. I., Shroot, B., Chandraratna, R. A. S., Hong, W. K., and Lotan, R. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids. Clin. Cancer Res., 5: 431-437, 1999.
37. Li, C., and Wan, Y. J. Differentiation and antiproliferation effect of retinoic acid receptor β in hepatoma cells. Cancer Lett., 124: 205-211, 1998.
38. Miller, W. H., Jr. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer (Phila.), 83: 1471-1482, 1998.